近年来,甘油三酯葡萄糖(The triglyceride-glucose, TyG)指数在心血管疾病相关研究中备受关注。TyG指数是基于甘油三酯(TG)与空腹血糖(FBG)构建的一个指标,与动脉粥样硬化性心血管病(atherosclerotic cardiovascular disease, ASCVD)有...近年来,甘油三酯葡萄糖(The triglyceride-glucose, TyG)指数在心血管疾病相关研究中备受关注。TyG指数是基于甘油三酯(TG)与空腹血糖(FBG)构建的一个指标,与动脉粥样硬化性心血管病(atherosclerotic cardiovascular disease, ASCVD)有着紧密联系。多项研究发现,TyG指数水平的变化和ASCVD的发生、发展以及预后情况息息相关。本研究旨在对TyG指数与ASCVD相关性的现有研究成果进行梳理总结,为进一步探究二者关系以及提升TyG指数在ASCVD防治中的应用价值提供参考依据。In recent years, the triglyceride-glucose (TyG) index has received extensive attention in cardiovascular disease-related research. The TyG index is an indicator constructed based on triglycerides (TG) and fasting blood glucose (FBG), and it has a close connection with atherosclerotic cardiovascular disease (ASCVD). A number of studies have found that changes in the TyG index level are closely related to the occurrence, development, and prognosis of ASCVD. The aim of this study is to comprehensively review and summarize the existing research results on the correlation between the TyG index and ASCVD, so as to provide a reference basis for further exploring the relationship between the two and enhancing the application value of the TyG index in the prevention and treatment of ASCVD.展开更多
2014年11月17日在美国心脏病学大会（AHA）上公布了备受关注的大型临床试验IMPROVE-IT研究结果,其结果全文即将发于《新英格兰医学杂志》。IMPROVE-IT（IMProved Reduction of Outcomes：Vytorin Efficacy International Trial[进一步...2014年11月17日在美国心脏病学大会（AHA）上公布了备受关注的大型临床试验IMPROVE-IT研究结果,其结果全文即将发于《新英格兰医学杂志》。IMPROVE-IT（IMProved Reduction of Outcomes：Vytorin Efficacy International Trial[进一步降低终点事件：葆至能疗效国际试验]）是一项在急性冠脉综合征的高危患者中确认葆至能（依折麦布＋辛伐他汀）与辛伐他汀单药相比的临床获益和安全性的国际多中心、双盲、随机对照临床试验。展开更多
文摘近年来,甘油三酯葡萄糖(The triglyceride-glucose, TyG)指数在心血管疾病相关研究中备受关注。TyG指数是基于甘油三酯(TG)与空腹血糖(FBG)构建的一个指标,与动脉粥样硬化性心血管病(atherosclerotic cardiovascular disease, ASCVD)有着紧密联系。多项研究发现,TyG指数水平的变化和ASCVD的发生、发展以及预后情况息息相关。本研究旨在对TyG指数与ASCVD相关性的现有研究成果进行梳理总结,为进一步探究二者关系以及提升TyG指数在ASCVD防治中的应用价值提供参考依据。In recent years, the triglyceride-glucose (TyG) index has received extensive attention in cardiovascular disease-related research. The TyG index is an indicator constructed based on triglycerides (TG) and fasting blood glucose (FBG), and it has a close connection with atherosclerotic cardiovascular disease (ASCVD). A number of studies have found that changes in the TyG index level are closely related to the occurrence, development, and prognosis of ASCVD. The aim of this study is to comprehensively review and summarize the existing research results on the correlation between the TyG index and ASCVD, so as to provide a reference basis for further exploring the relationship between the two and enhancing the application value of the TyG index in the prevention and treatment of ASCVD.
文摘2014年11月17日在美国心脏病学大会（AHA）上公布了备受关注的大型临床试验IMPROVE-IT研究结果,其结果全文即将发于《新英格兰医学杂志》。IMPROVE-IT（IMProved Reduction of Outcomes：Vytorin Efficacy International Trial[进一步降低终点事件：葆至能疗效国际试验]）是一项在急性冠脉综合征的高危患者中确认葆至能（依折麦布＋辛伐他汀）与辛伐他汀单药相比的临床获益和安全性的国际多中心、双盲、随机对照临床试验。
